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Abstract: The occurrence of diverse oligopeptides in cyanobacteria, including the 
cyanotoxins microcystins, has been recently used to classify individual clones into  
sub-specific oligopeptide chemotypes, whose composition and dynamics modulate 
microcystin concentrations in cyanobacterial blooms. Cyanobacterial chemotyping allows 
the study of the ecology of chemotypical subpopulations, which have been shown to 
possess dissimilar ecological traits. However, the stability of chemotypes under changing 
abiotic conditions is usually assumed and has not been assessed in detail. We monitored 
oligopeptide patterns of three strains of Microcystis aeruginosa under different nutrient and 
light conditions. MALDI-TOF MS revealed alterations in the microcystins signatures 
under N and P poor conditions and high light intensities (150 and 400 μmol photons 
m−2s−1). Variations in the general oligopeptide composition were caused by a gradual 
disappearance of microcystins with low relative intensity signals from the fingerprint. The 
extent of such variations seems to be closely related to physiological stress caused by 
treatments. Under identical clonal compositions, alterations in the oligopeptide fingerprint 
may be misinterpreted as apparent shifts in chemotype succession. We discuss the nature 
of such variations, as well as the consequent implications in the use of cyanobacterial 
chemotyping in studies at the subpopulation level and propose new guidance for the 
definition of chemotypes as a consistent subpopulation marker. 
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1. Introduction 
Freshwater cyanobacteria are well known for their occasional massive proliferation in temperate 
water bodies during late summer periods. Cyanobacterial blooms are of public health concern, due to 
the ability of many genera to produce a wide range of toxins and other bioactive compounds [1].  
An important group of these compounds are non-ribosomal peptides, termed onwards oligopeptides. 
Microcystins (MCs), a group of potent hepatotoxins, are one of these compounds.  
The traditional cyanobacterial taxonomy following botanical criteria is based mainly on morphological 
features. However, the existence of transitional populations with wide morphological variations [2], 
together with the observed loss of original morphological features under culture conditions [3],  
implies a remarkable polymorphism, which has raised discussions about the validity of taxonomic 
classification with morphological criteria alone. Indeed, from a toxicological standpoint, it is well 
known that morphological characteristics do not correlate well with toxin profiles, which have been 
observed to vary widely [4]. 
Oligopeptides are produced by non-ribosomal peptide synthases (NRPS) [5], with the exception  
of cyclamides and microviridins, which are synthesized by ribosomic pathways. More than  
600 structural variants of oligopeptides have been described, which have been classified in seven 
classes: aeruginosins, cyanopeptolins, microcystins, microviridins, microginins, anabaenopeptins and 
cyclamides [6]. The ability of cyanobacteria to produce oligopeptides is determined by the presence or 
absence of NRPS-encoding gene-clusters [7]. Cyanobacterial cells can present any combination of 
gene clusters, generating a specific pattern of oligopeptide production, which can be used as a 
characterizing oligopeptide fingerprint. The coexistence of individuals with distinct oligopeptide 
compositions within a population has been reported [8]. This finding allowed the use of distinct 
oligopeptide fingerprints as subspecific cyanobacterial markers to divide populations into 
oligopeptide-based subpopulations or chemotypes [9], which have been observed to possess different 
ecological traits [10]. Besides, MC concentrations in the course of the bloom often display marked 
temporal variations of up to several orders of magnitude (e.g., [11]) that represent one of the main 
hindrances to evaluate the risks associated with cyanobacterial blooms. Since MC is produced 
constitutively, its synthesis varies only about three-fold and is related to growth or cell division  
rates [12]. These variations cannot be explained by physiological changes at the individual level. 
Conversely, the relative abundance of dissimilar chemotypes in natural communities, as well as the 
shifts in chemotypical subpopulations, have been shown to be responsible for the observed varying MC 
concentrations [13] and, consequently, have to be considered critical factors modulating bloom toxicity. 
Although changes in the synthesis of individual oligopeptides under changing abiotic conditions 
have been examined [14–16], these differences have not been assimilated in the context of the 
conservation of oligopeptide fingerprints and its evaluations as a consistent chemotype marker. 
Understanding potential variations in the peptide composition of clonal strains is crucial for tracking 
the succession of chemotypical subpopulations in natural systems and, thereby, investigate their 
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ecology. To evaluate their stability, we tracked oligopeptide compositions of three clonal strains of 
Microcystis aeruginosa producing a wide range of microcystin variants and cultured under different 
scenarios. We focused on M. aeruginosa, a species that has been pointed out as the most important 
microcystin producer in Mediterranean latitudes [11,17]. Selected strains were exposed to N and P 
reductions and different light intensities. Their oligopeptide contents were analyzed by matrix assisted 
laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) to determine whether 
physiological stress causes alterations in oligopeptide fingerprints, which may have major implications 
when delimiting chemotypes and interpreting their dynamics under natural conditions. 
2. Results  
2.1. Oligopeptide Compositions  
A total of 1401 samples (colonies or groups of free cells) were analyzed by MALDI-TOF MS for 
their qualitative oligopeptide composition, generating a pool of more than 15,500 mass signals 
corresponding to, among others, 10 previously described oligopeptides [18]. Obtained data were used 
to construct an oligopeptide presence/absence matrix for each strain and condition (Figures 1 and 2). 
The selected strains produced mass spectra containing a wide range of putative MCs congeners and 
one cyanopeptolin variant (Table 1). Strain UAM254 showed a peptide composition consisting of  
a range of nine MC-variants. Strain UAM264 and UAM265 provided identical peptide patterns, with 
nine MC variants and one cyanopeptolin (cyanopeptolin 1006A, 1007.5 Da). The most intense signals 
corresponded to MC-LR, MC-RR and MC-YR, independently of the analyzed strain. 
2.2. Growth Rates 
We employed reductions in growth rates versus controls as a proxy of the fitness of the cultures 
under assayed conditions and, thereby, evaluate the effectiveness of treatments. N-poor treatment 
caused significant decreases in growth rates in two of the three analyzed strains, while P-poor only 
caused significant reductions in the growth rates of one strain (Table 2). UAM254 showed similar 
growth rates under control and P-poor treatments, significantly higher than those observed in the  
N-poor culture. Strain UAM264 did not show differences in growth rates between control and both  
N- and P-poor conditions. Nutrient treatments also induced reductions in growth rates in strain 
UAM265. In the light intensity experiment, non-colonial strain UAM254 exhibited under medium 
light (LM) and high light (LH) treatments significantly lower growth rates than control (low light; LL). 
Strain UAM264 also showed lower growth rates when compared to control, although differences were 
only statistically significant under LM treatment. Strain UAM265 did not present positive growth rates 
under high light conditions (LH) and started to decline a few days after inoculation. Although some 
colonies of this culture were analyzed, they presented poor pigmentation and produced only mass 
spectra with extremely low signals and were, hence, excluded from the analysis. Cultures under LM 
treatment presented significantly lower growth rates than under low light conditions (LL). 
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Figure 1. Presence/absence matrices of oligopeptides for strains UAM254, UAM264  
and UAM265 under N- and P-poor treatments. Columns show previously described 
oligopeptides, whereas rows represent the analyzed samples, sorted by nutrient treatment 
applied and time of sampling (days). Filled/colored cells correspond to presence; blank 
cells stand for absence.  
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Figure 2. Presence/absence matrices of oligopeptides for strains UAM254, UAM264 and 
UAM265 under different light intensities. Columns show previously described oligopeptides, 
whereas rows represent the analyzed samples, sorted by light intensity treatment applied 
and time of sampling (days). Filled/colored cells correspond to presence; blank cells stand 
for absence. 
 
Table 1. Detected oligopeptides by MALDI-TOF MS for each analyzed strain and their 
respective protonated m/z ratio. 
Peptide Name Protonated m/z  
[M + H+] (Da)  
UAM254 UAM264 UAM265 
Desmethyl-Mcyst-LR 981.5 x x x 
Mcyst-LR 995.6 x x x 
Cyanopeptolin 1006A 1007.5   x x 
Desmethyl-Mcyst-RR 1024.6 x x x 
Mcyst-FR 1029.5 x x x 
Desmethyl-Mcyst-YR 1031.5 x x x 
Mcyst-RR 1038.6 x x x 
Mcyst-YR 1045.5 x x x 
Mcyst-H4YR 1049.6 x x x 
Mcyst-WR 1068.6 x x x 
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Table 2. Growth rates and relative intensity threshold for each strain and treatment. 
Strain  Growth rates (day−1) Relative intensity threshold (a) 
Strain UAM254 
NC 0.146 0.04 
NN 0.108 (*) 0.34 
NP 0.181 0.04 
LL 0.135 0.08 
LM 0.060 (*) 0.25 
LH 0.070 (*) 0.25 
Strain UAM264 
NC 0.274 0 (stable) 
NN 0.205 0 (stable) 
NP 0.275 0 (stable) 
LL 0.206 0 (stable) 
LM 0.117 (*) 0.03 
LH 0.163 (*) 0.03 
Strain UAM265 
NC 0.383 0 (stable) 
NN 0.172 (*) 0.07 
NP 0.179 (*) 0.06 
LL 0.190 0 (stable) 
LM 0.103 (*) 0.03 
LH ----- ----- 
(a) Relative intensity threshold refers to the highest mean relative intensity among peptides, which presented 
interreplicate detection frequencies (IDFs) below 60% (i.e., unstable) NC: nutrient control; NN: N-poor 
treatment; NP: P-poor treatment; LL: low light (Control), 10 μmol photons m−2s−1; LM: medium light,  
150 μmol photons m−2s−1; LH: high light, 400 μmol photons m−2s−1; (*) Value significantly different to 
respective control treatments (ANOVA Holm-Sidak test; p < 0.05). 
2.3. Stability under N- and P-Reduction 
N-poor conditions did not cause changes in the oligopeptide pattern in strain UAM264. However, in 
the remaining strains, ascending hierarchical classification (AHC) did reveal variations under N-poor 
conditions (UAM254 and UAM265). Differences in the peptide patterns under the P-poor treatment 
could only be detected in one strain (UAM265). 
Until the last days before achieving the stationary phase, strain UAM254 provided, under both 
control and P-poor conditions, spectra containing mass signals corresponding to all the range of MCs, 
except for MC-FR, which could not always be detected (Figure 1). However, during the last days 
before achieving the stationary growth phase (t = 15 days), oligopeptide detection under control 
conditions (nutrient control; NC) was dramatically reduced to signals corresponding to MC-LR,  
MC-YR and MC-RR. Under N-poor conditions, spectra lacked many of the mass peaks (Figure 1), 
which corresponded to low intensity oligopeptides, while only signals that exhibited high mean 
relative intensities (>0.34; Table 3) were conserved. In fact, oligopeptide compositions recorded in the 
N-poor replicates were clearly separated in different clusters from those recorded in the control (except 
control at t = 15 days; Table S1A). AHC did not evidence significantly different oligopeptide profiles 
in P-poor cultures and control treatment (except control at t = 15 days), as most of the replicates were 
grouped in the same cluster.  
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Table 3. Interreplicate detection frequencies (IDFs) and average relative intensities of individual peptides. Peptides are classified as stable or 
unstable, according to their observed IDFs. Peptides with IDF ≤ 60% are considered unstable. 
IDF Average relative intensities IDF Average relative intensities 
Strain UAM254 Total NC NN NP    Total NC NN NP Strain UAM254 Total LL LM LH    Total LL LM LH 
MC-LR 91% 96% 75% 100% STABLE 1.00 1.00 1.00 1.00 MC-RR 79% 99% 76% 61% STABLE 0.97 1.00 0.89 0.98 
MC-RR 84% 94% 60% 100% STABLE 0.63 0.73 0.39 0.65 MC-LR 87% 97% 91% 70% STABLE 0.61 0.29 0.87 0.91 
MC-YR 78% 89% 42% 100% UNSTABLE 0.34 0.39 0.24 0.31 MC-YR 59% 91% 37% 34% UNSTABLE 0.25 0.24 0.23 0.28 
MC-H4YR 71% 80% 33% 98% UNSTABLE 0.18 0.20 0.17 0.16 Desmethyl-MC-RR 61% 93% 33% 41% UNSTABLE 0.24 0.25 0.15 0.29 
Desmethyl-MC-LR 76% 77% 52% 98% UNSTABLE 0.18 0.15 0.31 0.13 MC-WR 56% 93% 34% 24% UNSTABLE 0.16 0.17 0.15 0.14 
Desmethyl-MC-RR 66% 77% 20% 98% UNSTABLE 0.14 0.15 0.15 0.13 Desmethyl-MC-LR 32% 47% 20% 23% UNSTABLE 0.08 0.05 0.08 0.15 
MC-WR 61% 75% 10% 95% UNSTABLE 0.11 0.13 0.08 0.10 Desmethyl-MC-YR 8% 18% 1% 1% UNSTABLE 0.06 0.06 0.04 0.07 
Desmethyl-MC-YR 53% 76% 10% 67% UNSTABLE 0.08 0.09 0.11 0.06 MC-FR 14% 28% 7% 1% UNSTABLE 0.03 0.03 0.03 0.04 
MC-FR 26% 37% 0% 37% UNSTABLE  0.04 0.04 ND 0.04 MC-H4YR 13% 25% 5% 3% UNSTABLE  0.03 0.03 0.04 0.05 
                
Strain UAM264 Total NC NN NP    Total NC NN NP Strain UAM264 Total LL LM LH    Total LL LM LH 
MC-LR 99% 100% 97% 100% STABLE 0.99 0.97 0.99 1.00 MC-RR 100% 100% 100% 100% STABLE 0.80 1.00 0.71 0.60 
MC-RR 98% 100% 95% 98% STABLE 0.81 0.85 0.79 0.77 MC-LR 100% 100% 100% 100% STABLE 0.79 0.51 0.99 0.99 
MC-YR 99% 100% 95% 100% STABLE 0.47 0.53 0.39 0.47 Cyanopeptolin 1006A 100% 99% 100% 100% STABLE 0.33 0.15 0.36 0.56 
MC-H4YR 98% 99% 95% 100% STABLE 0.34 0.32 0.26 0.43 MC-YR 100% 100% 100% 100% STABLE 0.33 0.29 0.38 0.33 
Cyanopeptolin 1006A 99% 100% 97% 100% STABLE 0.30 0.26 0.37 0.30 MC-WR 100% 99% 100% 100% STABLE 0.20 0.17 0.25 0.18 
MC-WR 99% 100% 95% 100% STABLE 0.23 0.27 0.19 0.22 MC-FR   100% 99% 100% 100% STABLE 0.16 0.10 0.17 0.23 
MC-FR 97% 99% 92% 100% STABLE 0.10 0.10 0.09 0.11 MC-H4YR 98% 96% 99% 100% STABLE 0.12 0.06 0.17 0.13 
Desmethyl-MC-RR 96% 99% 90% 97% STABLE 0.09 0.09 0.10 0.09 Desmethyl-MC-RR 97% 99% 95% 95% STABLE 0.11 0.14 0.09 0.08 
Desmethyl-MC-LR 97% 99% 93% 97% STABLE 0.09 0.08 0.11 0.09 Desmethyl-MC-LR 95% 95% 94% 96% STABLE 0.06 0.04 0.06 0.07 
Desmethyl-MC-YR 91% 95% 88% 88% STABLE  0.05 0.05 0.05 0.05 Desmethyl-MC-YR 52% 75% 47% 23% UNSTABLE  0.03 0.03 0.03 0.04 
Strain UAM265 Total NC NN NP    Total NC NN NP Strain UAM265 Total LL LM LH    Total LL LM LH 
MC-LR 99% 100% 100% 96% STABLE 1.00 1.00 1.00 1.00 MC-RR 100% 100% 100% STABLE 0.88 1.00 0.71   
MC-H4YR 98% 100% 96% 99% STABLE 0.39 0.32 0.28 0.58 MC-LR 100% 100% 100% STABLE 0.74 0.57 0.99   
MC-RR 98% 99% 96% 99% STABLE 0.33 0.38 0.26 0.34 MC-YR 100% 100% 100% STABLE 0.42 0.38 0.48   
MC-YR 98% 99% 95% 99% STABLE 0.33 0.38 0.28 0.32 MC-WR 100% 100% 100% STABLE 0.23 0.20 0.27   
Cyanopeptolin 1006A 92% 96% 82% 96% STABLE 0.17 0.15 0.13 0.23 Cyanopeptolin 1006A 100% 100% 100% STABLE 0.23 0.13 0.36   
MC-WR 90% 99% 78% 91% STABLE 0.14 0.16 0.13 0.13 MC-H4YR 99% 99% 100% STABLE 0.15 0.09 0.23   
Desmethyl-MC-LR 88% 97% 69% 96% STABLE 0.13 0.12 0.09 0.17 Desmethyl-MC-RR 100% 100% 100% STABLE 0.12 0.14 0.10   
Desmethyl-MC-RR 67% 86% 27% 84% UNSTABLE 0.07 0.06 0.04 0.08 MC-FR 99% 99% 100% STABLE 0.10 0.08 0.14   
Desmethyl-MC-YR 58% 85% 26% 56% UNSTABLE 0.06 0.06 0.04 0.07 Desmethyl-MC-LR 98% 99% 96% STABLE 0.06 0.04 0.08   
MC-FR 53% 74% 29% 50% UNSTABLE  0.05 0.05 0.04 0.05 Desmethyl-MC-YR 77% 88% 60%   UNSTABLE  0.03 0.03 0.05   
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Strain UAM264 presented a conserved oligopeptide pattern under all treatments (Figure 1), as 
confirmed by AHC, which did not show separation between oligopeptide fingerprints in any of the 
nutrient treatments, when compared to control conditions, having most of the samples consistently 
assigned to the same cluster (Table S1B). 
Strain UAM265 showed differences between peptide patterns under control conditions and those 
obtained in both N- and P- poor treatments (Table S1C). Under P-poor conditions, interreplicate 
detection frequencies (IDFs) corresponding to oligopeptides with the lowest relative intensity signals 
(Desmethyl-MC-YR and MC-FR) falling below 60%, leading to instability of the peptide fingerprint. 
N-poor treatment showed mass peaks corresponding to Desmethyl-MC-YR, MC-FR and also 
Desmethyl-MC-RR as non-stable signals, with IDFs below 30% (Table 3). 
2.4. Stability under High Light Intensities  
Increased light irradiation (both LM and LH) caused variations in the peptide compositions in all 
strains. Strain UAM254 provided spectra with incomplete oligopeptide fingerprints (Figure 2), even 
under control conditions (10 μmol m−2s−1), lacking microcystins that presented average low relative 
intensity signals (≤0.08; Table 3). Peptide compositions of all light treatments were similar during the 
first days: AHC grouped replicates of LL and both higher light intensities in the same cluster for the 
initial days of growth (t = 6 days). However, in peptide patterns obtained in later days (t = 15,  
20 days), some peptides were missing, and replicates were therefore grouped in a different cluster by 
AHC, thereby evidencing variations in the oligopeptidic fingerprint (Table S2A). Under increased light 
conditions, mass signals corresponding to unstable oligopeptides showed always average relative 
intensities below 0.25 (Table 3). 
Oligopeptide compositions of strains UAM264 and UAM265 were consistent along treatments 
(Figure 2), with the exception of signal corresponding to Desmethyl-MC-YR, which showed the lowest 
relative intensities and could only be detected with IDFs below 60% under higher light intensities 
(Table 3). Based on its absence, AHC evidenced differences in peptide fingerprints under LM (both 
strains) and LH treatments (UAM264), when respectively compared to LL treatment (Table S2B,C). 
2.5. Extent of the Peptide Fingerprint Stability 
In general, a significant reduction in growth rates caused by treatments was followed by a gradual 
disappearance of microcystins mass signals with increasing relative intensities from oligopeptide 
profiles. The extent of the instability in the oligopeptidic fingerprint could hence be expressed as a 
relative intensity threshold, above which oligopeptides could be consistently detected. This threshold 
served as a metric of the extent of the instability, as well as a comprehensive delimitation between 
stable and unstable oligopeptides, according to the IDF criteria set. Strain UAM264 did not exhibit 
significant reductions in growth rates under nutrient limiting conditions and presented a stable 
oligopeptide fingerprint. In the light treatments though, where reduction in growth rates was significant 
(Table 2), differences were caused by Desmethyl-MC-YR, which was detected with the lowest mean 
relative intensity (0.03). Instability in the peptide fingerprint of strain UAM265 was caused by the 
absence of more peptides, whose maximal mean relative intensity (i.e., relative intensity threshold) 
ascended to 0.07 (Table 3). Non-colonial strain UAM254, showing the lowest growth rates, provided 
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incomplete peptide compositions, even under control conditions, presenting even higher relative 
intensity thresholds (0.34 and 0.24 in nutrient and light experiments, respectively; Table 3). 
3. Discussion 
MALDI-TOF MS has been pointed out as a useful and fast screening technique for the detection  
of cyanobacterial peptides, toxins and other bioactive compounds [8,19,20]. Recent studies dealt  
with the description of oligopeptide-based subspecific units or chemotypes, their ecology, dynamics  
and diversity [9,10,14,21]. However, this approach was based on the assumption that qualitative 
cyanobacterial oligopeptide composition was a stable feature, unaffected by abiotic conditions. Although 
there is abundant bibliography about the factors affecting synthesis of single oligopeptides [14–16] and 
cyanobacterial cultures have been observed to produce oligopeptides cyanopeptolin and microcystin 
for years under constant laboratory conditions [22,23], to our knowledge, no specific studies have 
related the observed differences in oligopeptide production under changing conditions in the context of 
the definition of chemotypes. Evaluating the consistency and conservation of oligopeptide fingerprints 
under varying environmental conditions, as well as understanding to what extent these are reliable in 
the frame of chemotype delimitation, is central for the correct interpretation of the dynamics of 
chemotypical subpopulations under field conditions. 
In our study, the different extent of the reduction in growth rates under different treatments 
evidences that strains show disparate susceptibility to nutrient deficiency. Intraspecific variations in 
growth rates under identical conditions have previously been described [24]. While strain UAM264 
grew with similar rates under all nutrient treatments during the studied period, UAM265 suffered both 
N- and P-deficiency (Table 2). Strain UAM254 exhibited overall lower growth rates, which may be 
attributed to its non-colonial morphology [25]. All in all, our observations evidence that strains may 
show different growth optima, even when belonging to the same chemotype (UAM264 and UAM265). 
In line with the varying susceptibility to changing nutrient and light conditions, we also found a 
different response among strains in terms of stability of their oligopeptide profiles. While peptide 
composition changed in strains UAM254 and UAM265 when nutrient and/or light conditions were 
altered, strain UAM264 conserved its original peptide pattern. Interestingly, variations in microcystin 
compositions were only observable when treatments caused significant reductions in growth rates. 
Strains unaffected by treatments (i.e., no statistically significant reductions in growth rates) provided 
highly conserved peptidic profiles. Indeed, missing oligopeptides always provided the lowest average 
relative intensities in the mass spectra (Table 3). 
The gradual disappearance of low intensity producing peptides enabled the use of a relative 
intensity threshold as an indicator of the extent of the oligopeptide fingerprint stability. Microcystins 
with average relative intensities below the relative intensity threshold (RIT) value could not be 
consistently detected. In other words, RITs can potentially be used as a threshold to discern between 
stable and unstable peptides. Together with the number of unstable peptides, RIT values were also 
higher when greater reductions in growth rates were observed (Table 2), denoting that the fitness of the 
culture, and the degree of conservation of microcystin signatures are closely linked. 
In light of these observations, we hypothesize that physiological effects caused by intense  
light irradiation and/or nutrient limitation, especially N-deficiency, causes an overall reduction in 
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microcystins cellular concentrations, leading to alterations in the oligopeptide profiles employed for 
chemotype delimitation. Under high light conditions, free microcystin concentration in the cell may be 
reduced as a result of covalent binding of microcystin to the cysteine residues of proteins involved in 
photosynthesis, as recently demonstrated by Zilliges et al. [26]. This binding was observed to be 
dramatically enhanced under high light conditions, suggesting that microcystins may play a role as a 
protein-modulating metabolite under oxidative stress conditions. Alternatively, a decrease in the 
NPRS/PKS enzyme complex activity as a result of physiological stress would explain an overall 
reduction in MC synthesis: The coexistence of multiple MC variants partially results from the 
NPRS/PKS multi-enzyme complex substrate inspecificity in the incorporation of amino acids in 
positions 2 and 4 [27]. A reduction in the activity of the NRPS/PKS enzyme complex would therefore 
reduce the synthesis of all coexisting MC congeners homogeneously, causing minority MC variants 
(i.e., those providing the lowest intensity signals) to fall below detection limits. Reduced NPRS 
activities under physiological stress are consistent with previous findings demonstrating that maximal 
oligopeptide concentrations are found under optimal growth conditions [15,16] and that MC production 
is directly and linearly correlated with growth rates [12]. A further plausible explanation refers to 
reductions in the availability of amino acids involved in oligopeptide synthesis as a result of  
N-limitation. Similarly, increased photosynthesis under high light irradiation would have an equivalent 
effect, raising the C/N cellular ratio and ultimately leading to N-deficiency. Nitrogen availability 
modulates the cellular amino acid composition, reducing nitrogen-rich amino acids, such as arginine, 
under limiting conditions [28]. All detected microcystin variants in our study contained one arginine in 
their structure, so that overall microcystin production would be homogenously reduced. Exceptionally, 
variants MC-RR and Desmethyl-MC-RR contain arginine in both positions 2 and 4. Interestingly, we 
observed reductions in the relative intensity of signals corresponding to MC-RR in favor of MC-LR 
(the co-dominant variant in the mass spectra) under both high light and N-poor conditions (Table 3). 
Reductions in MC-RR production among other variants under N-limiting conditions and high light 
intensities have been reported previously [28,29], evidencing that its synthesis is closely related to 
arginine availability. Desmethyl-MC-RR is also probably affected in this way, but changes in signals 
with initially low absolute intensities remain negligible in terms of relative intensity.  
Previous studies reported that MALDI-TOF MS shows preferential ionization of peptides 
containing arginine in their structure [30]. One could therefore concede that MALDI-TOF results may 
not represent the complete cellular oligopeptide composition, having non-arginine-containing peptides 
as underestimated signals close to or even below detection limits. As all MC variants detected in our 
study contained arginine, the presence of further oligopeptides cannot be discarded. However, 
variations in a peptide pattern with respect to controls (presence/absence or changes in relative 
intensities) have to be regarded as actual variations in the oligopeptide net production that transcend 
the mere alteration of the peptide fingerprint, raising important implications regarding the definition of 
the chemotype itself. For instance, UAM264 and UAM265 presented identical peptide compositions 
under control conditions and have therefore to be considered the same chemotype. However, in light  
of the observed variations in the general oligopeptide pattern under N and P limitation, the dilemma  
is evident: the same chemotype under nutrient rich conditions or two distinct chemotypes under  
limiting conditions? 
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The oligopeptide profiles of the selected strains in our study only represent a portion of the 
complete array of oligopeptides typically used for chemotype delimitation, and the observed 
fingerprint instability was caused by the loss of microcystin signatures. Although most oligopeptides 
are produced via non-ribosomal biosynthetic pathways, a generalization of our findings to other 
oligopeptide classes has to be done with caution. Further investigations should, hence, focus on 
addressing a wider range of bioactive compounds to assess whether our findings are applicable to other 
oligopeptide classes. Still, the distortion of oligopeptidic fingerprints, although consisting solely of 
microcystins, constitutes an unreported issue in the context of chemotypes definition. Assessing the 
instability of oligopeptide compositions is crucial for an unbiased interpretation of the dynamics of 
chemotypical subpopulations in natural systems. However, homogeneous criteria for chemotype 
delimitation are currently not available. In fact, studies dealing with the dynamics of chemotypical 
subpopulations show huge differences in terms of chemotype diversity. For instance, Rohrlack et al. [10] 
identified four Planktothrix chemotypes in Lake Steinsfjorden throughout a period of 33 years.  
In contrast, Welker et al. [9] found 37 different Microcystis chemotypes in Brno reservoir in a study 
period of five months. Although these studies focus on different genera and may not be comparable, 
chemotype delimitation was performed in each case using different methodologies. On the one hand, 
the inclusion of strains with similar, but not identical oligopeptide patterns in the same chemotype 
(Lake Steinsfjorden) lead to the definition of a low number of subpopulations. On the other hand, data 
on Lake Brno was analyzed on the basis that changes in individual oligopeptides implied a different 
chemotypical unit. Our study shows that such variations may occur within clonal subpopulations, 
suggesting that the number of chemotypes in Lake Brno could partially be overestimated. Sudden 
changes in abiotic conditions (e.g., nutrient inputs), together with the differences in physiological 
conditions among individuals within the same chemotype, may trigger changes in the recorded 
oligopeptide profiles, which may be misinterpreted as shifts in the chemotypical subpopulations, while 
the clonal composition of the population actually remains unchanged. Therefore, we believe  
that chemotypical delimitation needs to be done on the basis of the presence of high intensity 
oligopeptides, as the detection of low intensity producing microcystins has been shown to be highly 
dependent on the physiological condition of the subpopulation and is, therefore, not always possible. 
Thus, setting a relative intensity threshold to identify reliable (i.e., stable) oligopeptides for chemotype 
definition seems a plausible option to circumvent this problem. However, a definition of a relative 
intensity threshold to generally discern between “stable” and “potentially unstable” oligopeptides is 
still needed, given the differences in susceptibility to stressing conditions among strains and the 
variability in detection limits in the MALDI-TOF technique from laboratory to laboratory. Further 
research should, hence, focus on describing the relationship between the degree of instability in the 
oligopeptidic patterns (e.g., via RIT) and specific physiological indicators, which can normalize the 
observed intraspecific variations in growth optima. Still, our findings provide unreported evidence for 
variability in the detection of microcystin signatures, which may lead to a biased delimitation of 
oligopeptide-based chemotypes. While restricted to microcystins, such variability affects oligopeptide 
signatures as a whole and needs to be addressed to allow the definition of consistent chemotypical 
subpopulations that can be unequivocally identified under the complete range of natural conditions. 
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4. Experimental Section 
4.1. Microcystis aeruginosa Strains 
Three strains of M. aeruginosa were used, namely UAM254 (non-colonial morphotype), UAM264 
and UAM265 (colonial morphotypes), which were isolated between 1998 and 2000 from Santillana 
Reservoir, a eutrophic and typically monomictic water body located in Madrid, central Spain. 
Limnological features of the reservoir are described elsewhere [31]. After isolation, the strains  
were maintained as clonal cultures in a BG11 medium [32] under constant conditions at 28 °C and  
10 μmol photons m−2 s−1 illumination provided by continuous cool white fluorescent light. 
4.2. Experimental Setup 
Nutrient treatments were cultured under continuous light irradiance of 70 μmol photons m−2s−1.  
All experiments were conducted after 2 weeks acclimation period to assayed conditions. Nutrient 
control (NC) conditions used the original BG11 medium ([P] = 175 µM; [N] = 2 mM). N-poor (NN) 
treatment consisted in the use of a modified BG11 medium containing only 10% of the original NaNO3 
concentration ([N] = 200 µM), while P-poor treatment (NP) consisted in a modified BG11 medium 
containing only 10% of the original K2HPO4 concentration ([P] = 17.5 µM). Glassware containing  
P-poor medium was washed previously with HCl (10%) to eliminate P traces. Light experiments were 
carried out using the original BG11 medium under different continuous light intensities: low light (LL) 
conditions consisted in a 10 μmol photons m−2s−1 irradiance and were used as control for the 
comparison of oligopeptide compositions, while medium (LM) and high light (LH) conditions 
provided 150 and 400 μmol photons m−2s−1, respectively. Sterile glassware with treatment-specific 
nutrient medium was inoculated with 1 mL aliquots of the original cultures in the exponential phase 
and placed under the appropriate light conditions. The resulting cultures were maintained under the 
same temperature, and their growth was monitored by spectrophotometric readings at 750 nm. Culture 
growth rates were calculated for each treatment during the exponential phase [μ = ln(Nt/No)/Δt].  
4.3. MALDI-TOF MS Analysis 
During the active growth phase and until the stationary growth phase was achieved, individual 
colonies or free cells were collected for the determination of their oligopeptide compositions through 
MALDI-TOF MS. Twenty replicates for each strain-treatment-time combination were analyzed. 
Colony biovolume (for colonial strains) and optical density (for unicellular cultures) were correlated to 
cell numbers for each strain (data not shown), were used to indirectly ensure sufficient biomass in the 
samples (>6000 cells) and, thereby, obtain unambiguous mass spectra. Single colonies of at least  
0.03 mm3 or 5 μL of free cell suspension were collected with disposable glass capillaries and placed in 
0.2 mL Eppendorf tubes, which were allowed to dry at room temperature during 2 h. Ten microliters of 
an acetonitrile, ethanol and water (1:1:1) extractant solution, acidified with 0.03% (v/v) trifluoroacetic 
acid (TFA), were then added to each sample. Samples were introduced into liquid nitrogen for 2 h to 
induce cell lysis and stored at −80 °C until analyzed. For MS analysis, 0.5 μL of individual samples 
analyte solution were placed onto the matrix spots of a Prespotted AnchorChip (PAC 284/96 HCCA, 
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Bruker Daltonics, Bremen, Germany), which contain α-cyano-4-hydroxycinnamic acid (HCCA) as  
co-crystallizing matrix. Spots were allowed to dry at room temperature and were washed with 
ammonium phosphate (10 mM) for 5 s before MALDI-TOF analysis. Mass spectrometric analysis was 
performed on a Bruker Reflex MALDI mass spectrometer equipped with a time of flight (TOF) mass 
analyzer on positive ion detection mode and reflector mode. Acceleration voltage was set to 25 kV and 
mirror voltage to 26.3 kV. Mass spectra were accumulated from 1000 laser pulses scanning the entire 
sample spot for a mass range of 500–2000 Da. 
4.4. Data Processing 
The resulting mass spectra were processed using Bruker FlexAnalysis software (version 3.0).  
The SNAP algorithm (Bruker Daltonics, Bremen, Germany) was used for mass determination using a 
signal to noise threshold of 6. Putative oligopeptides were identified according to their mass/charge 
ratio, compared with previously described oligopeptides [18]. The occurrence of Na and K adducts in 
the ionization was also examined, and their assignment was corrected to the appropriate protonated 
oligopeptide. Mass signals that could not be assigned to any previously described oligopeptide were 
excluded from the analysis. Relative intensities were calculated based on the absolute signal intensity 
of the highest identified oligopeptide peak in the mass spectrum. Obtained data were used to construct 
a matrix for each strain, illustrating the presence or absence of oligopeptides along the different 
treatments and sampling times. To evaluate the differences between the oligopeptide fingerprints 
recorded under different treatments, an ascending hierarchical clustering (AHC) was conducted: for 
each strain, multiple datasets consisting of each treatment and its respective control were constructed. 
The resulting individual datasets were examined by AHC, which analyzed dissimilarities using 
Euclidean distances and applying Ward’s agglomeration method. The number of clusters was 
predefined (k = 2), so that data variability within the dataset was separated into two clusters.  
The resulting clusters contained samples with similar (or identical) peptide compositions. 
To evaluate whether applied treatments caused changes in the peptide composition compared to 
controls, the percentage of treatment and control replicates assigned to each cluster was examined. When 
treatments induced variations in the peptide fingerprint, control replicates were majorly and selectively 
concentrated in cluster A, while most of the treatment replicates were grouped in cluster B. Conversely, 
when assayed conditions did not cause changes in the peptide composition, non-selective assignment 
occurred, having samples corresponding to both control and treatment majorly assigned to the same cluster. 
Given that chemotypical subpopulations are delimited by their respective peptide compositions, 
which are usually defined by the presence of individual oligopeptides, the gain or loss of one or more 
peptides would imply a change in the chemotype-specific fingerprint. Conserved oligopeptide patterns 
were, hence, considered those which conserved their complete oligopeptide combination regardless of 
treatments and time. Therefore, stability was analyzed as the consistency in detection of individual 
peptides. Detection frequencies were expressed as a percentage of positive detections among  
same-treatment replicates (termed onwards IDF, interreplicate detection frequency) and aim to provide a 
metric of the variations in detection of individual peptides between replicates. Oligopeptides presenting 
IDFs below 60% were regarded as unstable signals and consequently considered to account for 
changes in the oligopeptide fingerprint. This value aimed to provide a conservative limit to discern between 
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stable and unstable peptides. To express the extent of the fingerprint instability, a relative intensity 
threshold (RIT) was calculated, which represents the maximal mean relative intensity among unstable 
oligopeptides (i.e., those showing IDFs below 60%). RIT values represent the delimitation, in terms of 
mass spectral relative intensity, between stable and unstable peptides for each treatment and strain. 
5. Conclusions 
The stability of oligopeptide fingerprints used for the definition of cyanobacterial chemotypes has 
not been assessed. Our results evidence that oligopeptide fingerprints may be subject to distortion 
under suboptimal physiological conditions, consisting in the gradual loss of low intensity signals 
corresponding to minor microcystin variants. Changes in the oligopeptide patterns may be 
misinterpreted as shifts in the composition of chemotypes and may lead to overestimation of their 
diversity in natural populations. Therefore, criteria for the definition of oligopeptide chemotypes 
should be based on the detection of high intensity producing peptides, which can be consistently 
detected over the complete range of environmental conditions, allowing an accurate analysis of the 
dynamics of chemotypes in natural ecosystems.  
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